NHS Wasting Tens Of Millions Each Year On Expensive Insulin Contrary To NICE Guidance

NHS Wasting Tens Of Millions Each Year On Expensive Insulin Contrary To NICE Guidance
A drive by the drug industry to promote new, more expensive type of insulins (known as analogue insulins) for people with type 2 diabetes is estimated to have cost the NHS at least £250m extra over the past five years. Yet for most people with type 2 diabetes, the extra cost does not correspond to the equivalent extra benefit. A joint investigation by the BMJ and Channel 4 News argues that …
Read more on Medical News Today

Roche’s Avastin Blocked In US, Partly Backed In EU
Roche’s Avastin Blocked In US, Partly Backed In EU
Read more on FOX Business

Q+A-What is the status of Avastin in breast cancer?
WASHINGTON, Dec 16 (Reuters) – U.S. regulators have started the process of revoking the approval of Roche Holding drug Avastin for treating breast cancer. European officials also have recommended restrictions.
Read more on AlertNet